The Food and Drug Administration (FDA) gave the thumbs-up to a drug designed to prevent people with mild to moderate COVID-19 from getting sicker.
The drug, a monoclonal antibody, will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and distributing the medicine fairly will be a challenge.
The FDA is allowing the drug on the market under its emergency-use provision, which requires a lower standard of evidence than outright approval.
This antibody is made by Eli Lilly. President Trump got a similar medication made by Regeneron — but that product is still under review at the FDA.
At Vidal Medical Concierge, located in Juno Beach and serving Jupiter, Palm Beach Gardens, West Palm Beach, and the nearby areas, we continue to monitor the latest developments in treatments for COVID-19, and continue to advise the patients of Dr. Yael Vidal with regard to relevant new treatments.